Blood test may predict immunotherapy success in head and neck cancer
NCT ID NCT07396259
First seen Feb 10, 2026 · Last updated May 20, 2026 · Updated 20 times
Summary
This study looks at whether a simple blood test can help doctors predict how well immunotherapy will work for people with head and neck cancer. Researchers will measure certain markers on tumor cells found in the blood and compare them to standard tissue tests. The goal is to make treatment decisions easier without needing repeated tissue biopsies. About 150 participants will be followed to see how their cancer responds.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Linkou Chang Gung Memorial Hospital
RECRUITINGTaoyuan, City, 333, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.